British Journal of Dermatology | 2019
Patient‐reported health not associated with keratinocyte carcinoma treatment choice in a Medicare cohort of older adults
Abstract
Keratinocyte carcinomas (KCs; basal cell carcinoma [BCC] and squamous cell carcinoma [SCC]), are common in older adults, with 2.1 million yearly in United States (US) Medicare patients.1 Common treatments include destruction (typically electrodessication and curettage), surgical excision, and Mohs micrographic surgery (MMS), all of which can offer cure rates >90%2,3 (highest for MMS, followed by excision, then destruction).